Demography of patient population
| Turbuhaler | pMDI +Nebuhaler | |
|---|---|---|
| Results expressed as mean (SD) [range] where appropriate. | ||
| IGCS, inhaled glucocorticosteroids; pMDI, pressurised metered dose inhaler. | ||
| n | 57 | 55 |
| Male/female | 35/22 | 39/16 |
| Age (y) | 10.7 (2.9) [6–16] | 10.3 (2.8) [6–16] |
| Height (cm) | 145.6 (15.2) [114–183] | 143.0 (14.6) [121–175] |
| Weight (kg) | 42.0 (16.7) [20–120] | 40.0 (14.2) [21–76] |
| FEV1 (l) | 1.08 (0.36) [0.43–1.90] | 0.98 (0.34) [0.50–1.81] |
| FEV1 (%PNV) | 44.8 (9.0) [25.8–60.4] | 43.4 (10.1) [25.7–59.8] |
| Receiving IGCS | 33 | 39 |
| Receiving short acting β2 agonists | 49 | 50 |
| Withdrawn | 6 | 3 |